Pituitary adenylate cyclase-activating polypeptides (PACAP) have potent regulatory and neurotrophic activities on superior cervical ganglion (SCG) sympathetic neurons with pharmacological profiles consistent for the PACAP-selective PAC 1 receptor. Multiple PAC 1 receptor isoforms are suggested to determine differential peptide potency and receptor coupling to multiple intracellular signaling pathways. The current studies examined rat SCG PAC 1 receptor splice variant expression and coupling to intracellular signaling pathways mediating PACAP-stimulated peptide release. PAC 1 receptor mRNA was localized in over 90% of SCG neurons, which correlated with the cells expressing receptor protein.The neurons expressed the PAC 1 (short)HOP1 receptor but not VIP/PACAP-nonselective VPAC 1 receptors; low VPAC 2 receptor mRNA levels were restricted to ganglionic nonneuronal cells. PACAP27 and PACAP38 potently and efficaciously stimulated both cAMP and inositol phosphate production; inhibition of phospholipase C augmented PACAP-stimulated cAMP production, but inhibition of adenylyl cyclase did not alter stimulated inositol phosphate production. Phospholipase C inhibition blunted neuron peptide release, suggesting that the phosphatidylinositol pathway was a prominent component of the secretory response. These studies demonstrate preferential sympathetic neuron expression of PACAP-selective receptor variants contributing to regulation of autonomic function.The identification of pituitary adenylate cyclase-activating polypeptide (PACAP) 1 and vasoactive intestinal peptide (VIP)/ PACAP receptors has broadened our understanding of the mechanisms underlying the regulatory and neurotrophic roles of this family of peptides. The PACAP precursor molecule is tissue-specifically posttranslationally processed to two biologically active ␣-amidated products, PACAP38 (pro-PACAP-(131-168)) and PACAP27 (pro-PACAP-(131-157)) (1-5), which share amino acid homology with VIP. In the nervous system, PACAP induces neuronal calcium flux, facilitates membrane depolarization, and increases spike frequency (6 -8, 10).2 PACAP peptides also enhance neuroblast survival, proliferation, differentiation, and neurite outgrowth and prevent neuronal apoptosis upon growth factor or stimulus withdrawal and ischemic insult (11-16).The cloning of cDNAs for three putative seven-transmembrane G-protein-coupled receptors for VIP and PACAP demonstrated receptor subtype diversity and functional heterogeneity (17-25). The PACAP-selective PAC 1 receptor demonstrates high affinity for only PACAP38 and PACAP27 and is coupled to multiple intracellular signaling cascades. The VPAC 1 and VPAC 2 receptors, in contrast, exhibit approximate equal high affinity for the PACAP38, PACAP27, and VIP peptides and are coupled to adenylyl cyclase. Multiple PAC 1 receptor isoforms result from the alternative splicing of two exons in the aminoterminal extracellular domain and/or two (HIP and HOP) exons in the third cytoplasmic loop (19,23,24,26). Cell-specific expression of PAC 1 receptor sp...